Monitoring and Management of Patients on Therapy for Chronic Hepatitis B
This answer is incorrect. For patients who are HBeAg-positive at baseline, monitoring for loss of HBeAg is strongly recommended and is considered an important parameter to follow. If HBeAg seroconversion does occurs, it will take place before HBsAg seroconversion. Thus, waiting for HBsAg seroconversion to occur before monitoring for HBeAg seroconversion would not be logical. Further, the likelihood of HBsAg seroconversion is extremely low and markedly less probable than HBeAg seroconversion.
Choose another answer: